Skip to content
PICO Portalanswers from OpenAlex

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure

PaperCitations, authors & open-access status

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure is a paper indexed in PICO Portal from OpenAlex.

How many citations does Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure have?

PICO Portalcitation count

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure has 53 citations in the OpenAlex counts PICO Portal stores.

When was Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure published?

PICO Portalyear

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure has 2022 year in the PICO Portal index.

What is the open-access status of Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure?

PICO Portaloa status

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure has hybrid oa status in the PICO Portal index.

What is the DOI of Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure?

PICO Portaldoi

The DOI for Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure is on the source record.

What is the PMID of Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure?

PICO Portalpmid

The PMID for Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure is on the source record.

What is the OpenAlex record for Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure?

PICO Portalopenalex

The OpenAlex for Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial